Table 3.
Clinical domain |
Authors (year) |
Study design | Jadad score |
Participants∗∗ (age range) | Tulsi extract |
Intervention | Comparator | Outcome measure(s) |
Adverse events (s) |
|
---|---|---|---|---|---|---|---|---|---|---|
Duration∗ | Dosage | |||||||||
Neurocognition | Sampath et al. (2015) [81] | Randomized, double-blind, placebo controlled clinical trial |
5 | 40 healthy adults (18–30 years) |
Ethanolic tulsi leaves capsules |
4 weeks | 300 mg/day before meals |
Cellulose capsules |
Cognitive flexibility, attention, Improved working memory only after day 15 |
None |
Saxena et al. (2012) [82] | Randomized, double-blind, placebo-controlled |
4 | 150 adults, stress (18–65 years) |
OCIBEST† whole plant capsules |
6 weeks | 400 mg 3 times/day after meals |
Cellulose capsules |
Reduction in stress related symptoms: fatigue, sleep and sexual problems |
None | |
Verma‡ et al. (2012) [72] | Clinical trial | 0 | 24 adults, psychosomatic (60–80 years) |
powder whole plant tulsi |
12 weeks | 3 g × 2/day | None | Reduced anxiety significantly lowered biological age score |
None | |
Bhattacharyya et al. (2008) [83] | Clinical trial | 1 | 35 adults with GAD (18–60 years) |
Ethanolic tulsi leaves capsules |
8 weeks | 500 mg 2x daily after meals |
None | Self-reported questionnaire, ↓anxiety, stress, & depression |
None |
GAD = generalized anxiety disorder.
∗ Intervention duration is the time the intervention was administered excluding any washout periods.
∗∗ Participants include both control and intervention groups completing the study and excluded any drop-outs.
† OCIBEST is product of natural remedies and contains tulsi whole plant.
‡Authors also reported findings from glucose and lipid profile for 5 of the participants and found lipid profile significantly improved.